EdgarLookup

AN2 Therapeutics, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Financials Insiders
Insider Title Type Shares Price Value Date
Eizen Joshua M See Remarks Sale 2,819 $1.14 $3,214 Nov 4, 2025
Prior Stephen David Chief Strategy Officer Sale 765 $1.14 $872 Nov 4, 2025
Marks Gilbert Lynn Award / Grant 10,367 Oct 10, 2025
Aziz Kabeer Award / Grant 10,367 Oct 10, 2025
Martin Patricia A. Award / Grant 3,274 Oct 10, 2025
Aziz Kabeer Award / Grant 11,875 Jul 10, 2025
Marks Gilbert Lynn Award / Grant 11,875 Jul 10, 2025
Martin Patricia A. Award / Grant 3,750 Jul 10, 2025
Easom Eric Chief Executive Officer Purchase 10,000 $1.07 $10,700 Jun 2, 2025
Leonard Braden Michael Sale 425,000 $1.01 $429,250 May 28, 2025
FitzPatrick Margaret M Purchase 8,610 $1.18 $10,160 May 28, 2025
Leonard Braden Michael Sale 200,000 $1.09 $218,000 May 28, 2025
Zakrzewski Joseph S Award / Grant 10,523 Apr 10, 2025
Aziz Kabeer Award / Grant 9,705 Apr 10, 2025
Martin Patricia A. Award / Grant 3,065 Apr 10, 2025
Marks Gilbert Lynn Award / Grant 9,705 Apr 10, 2025
Chanda Sanjay Chief Development Officer Award / Grant 50,250 Feb 26, 2025
Day Lucy Chief Financial Officer Award / Grant 46,500 Feb 26, 2025
Eizen Joshua M See Remarks Award / Grant 58,500 Feb 26, 2025
Easom Eric Chief Executive Officer Award / Grant 145,250 Feb 26, 2025
Prior Stephen David Chief Strategy Officer Award / Grant 28,000 Feb 26, 2025
Day Lucy Chief Financial Officer Sale 2,957 $1.34 $3,962 Jan 3, 2025
Chanda Sanjay Chief Development Officer Sale 2,957 $1.34 $3,962 Jan 3, 2025
Prior Stephen David Chief Strategy Officer Sale 2,029 $1.34 $2,719 Jan 3, 2025
Eizen Joshua M See Remarks Sale 9,663 $1.34 $12,948 Jan 3, 2025
Martin Patricia A. Award / Grant 3,166 Dec 19, 2024
Aziz Kabeer Award / Grant 8,972 Dec 19, 2024
Marks Gilbert Lynn Award / Grant 8,972 Dec 19, 2024
Zakrzewski Joseph S Award / Grant 9,816 Dec 19, 2024
Readnour Robin Shane Award / Grant 9,077 Dec 19, 2024
Readnour Robin Shane Purchase 5,000 $1.49 $7,450 Dec 9, 2024
Readnour Robin Shane Purchase 12,500 $1.39 $17,375 Nov 27, 2024
Zakrzewski Joseph S Purchase 2,000 $1.40 $2,800 Nov 27, 2024
Readnour Robin Shane Purchase 25,000 $1.16 $29,000 Nov 20, 2024
Zakrzewski Joseph S Purchase 20,000 $1.00 $20,000 Nov 19, 2024
Easom Eric Chief Executive Officer Purchase 50,000 $1.00 $50,000 Nov 18, 2024
Prior Stephen David Chief Strategy Officer Award / Grant 10,125 Nov 4, 2024
Eizen Joshua M See Remarks Award / Grant 31,500 Nov 4, 2024
Leonard Braden Michael Purchase 1,500,000 $1.04 $1,560,000 Aug 14, 2024
RA Capital Healthcare Fund LP Sale 3,410,335 $1.08 $3,683,162 Aug 9, 2024
Eizen Joshua M Chief Legal Officer Award / Grant 60,000 Jul 10, 2024
Eckburg Paul Chief Medical Officer Award / Grant 30,000 Mar 15, 2024
Day Lucy Chief Financial Officer Award / Grant 27,500 Mar 15, 2024
Eizen Joshua M Chief Legal Officer Award / Grant 30,000 Mar 15, 2024
Krause Kevin Michael Chief Strategy Officer Award / Grant 30,000 Mar 15, 2024
Chanda Sanjay Chief Development Officer Award / Grant 27,500 Mar 15, 2024
Easom Eric Chief Executive Officer Award / Grant 99,000 Mar 15, 2024
Day Lucy Chief Financial Officer Award / Grant 27,500 Mar 15, 2024
Eizen Joshua M Chief Legal Officer Award / Grant 30,000 Mar 15, 2024
Krause Kevin Michael Chief Strategy Officer Award / Grant 30,000 Mar 15, 2024